No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA —Merck & Co Inc and AstraZeneca have announced that an independent committee of advisers to the U.S. Food and Drug Administration (FDA) will evaluate their application for the expanded…
Read More
INDIA – AstraZeneca India has introduced its rare disease drug Selumetinib for patients in India following regulatory approval, marking its entry into rare disease therapy in the country. AstraZeneca India,…
Read More
INDIA – AstraZeneca India has received the go-ahead from Central Drugs Standard Control Organization (CDSCO) to market its drug Durvalumab for biliary tract cancer (BTC) treatment in India. The science-led…
Read More
USA — Evusheld, a preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the United States because it is unlikely to be effective against the coronavirus…
Read More
USA— AstraZeneca has struck a deal to buy US-based biopharmaceutical firm CinCor Pharma Inc for up to US$1.8 billion to strengthen its pipeline of heart and kidney drugs and grow…
Read More
USA— According to a recent Food and Drug Administration (FDA) communication, Lumoxiti for injection will be permanently discontinued in the US market by August 31, 2023. The FDA approved Lumoxiti,…
Read More
AFRICA – Pharma giants AstraZeneca and Pfizer have reiterated their focus on sustainability with their on-going carbon footprint funding. AstraZeneca has set scope 1 and 2 target featuring carbon emissions…
Read More
UAE – Biopharma giant AstraZeneca and G42 Healthcare, an AI-powered healthcare company, have teamed up to locally manufacture innovative drugs in the Emirate of Abu Dhabi. The strategic partnership deal…
Read More
AFRICA – AstraZeneca is set to establish a new liver cancer research partnership in countries in Africa to accelerate improved understanding and care for a form of liver cancer. In…
Read More
INDIA – AstraZeneca Pharma India Ltd. has appointed Dr. Sanjeev Panchal as Country President and Managing Director for a three-year term beginning January 1, 2023. He succeeds Gagandeep Singh Bedi,…
Read More